This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Ohio State University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Janet Antwi: Innovator in Antimicrobial Research
Introduction
Janet Antwi is a notable inventor based in Columbus, Ohio. She has made significant contributions to the field of antimicrobial research, focusing on small molecule antimicrobials. Her work is particularly relevant in the context of increasing bacterial infections and the need for effective treatments.
Latest Patents
Janet Antwi holds 1 patent for her invention related to small molecule antimicrobials. The patent describes compounds and compositions that include JH-144, TH-04, or TH-08, either individually or in combination. These compounds can be formulated with carriers and may include pharmaceutically acceptable excipients, films, biofilms, or edible films. The methods of use outlined in her patent suggest that the composition can be administered to subjects suffering from bacterial infections. Additionally, the composition can be applied to surfaces to eliminate or reduce bacterial presence.
Career Highlights
Janet Antwi is affiliated with The Ohio State University, where she continues her research and development in antimicrobial solutions. Her work is crucial in addressing the challenges posed by antibiotic resistance and the need for innovative treatment options.
Collaborations
Janet has collaborated with notable colleagues such as Gireesh Rajashekara and Ulyana Munoz Acuna. These collaborations enhance the research efforts and broaden the impact of her work in the scientific community.
Conclusion
Janet Antwi's contributions to antimicrobial research through her innovative patents highlight her role as a leading inventor in this critical field. Her work not only addresses current health challenges but also paves the way for future advancements in antimicrobial therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
